The COVID-19 pandemic will have a limited negative impact on the Latin American GI endoscopy device market; although many screening and elective interventional procedures will be postponed, urgent procedures will continue to be performed. Once the market recovers, it will expand moderately through 2029 because of the improving access to health care across the region and the concerted efforts of health systems to implement extensive screening programs, especially for CRC. Having said that, the unstable economic conditions in the region, as well as the practice of reusing GI endoscopy devices among health care facilities, will act as limiting factors for the market.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for GI endoscopy devices in Latin America across a 10-year period.
The COVID-19 pandemic will affect the GI endoscopy device market.
To what extent will the COVID-19 pandemic impact the GI endoscopy device market in Latin America?
Which procedures are going to be affected the most during the pandemic?
How quickly are procedure volumes expected to rebound?
Few Latin American countries have extensive CRC screening programs.
In countries with such screening programs, what impact do these programs have on GI endoscopy procedure volumes?
What are other major factors affecting procedure volume growth in these countries?
The videoscope system market will grow moderately during the forecast period in Latin America.
What are the factors that will limit the growth of this market?
Which country will purchase the greatest number of videoscopes during the forecast period?
The ERCP device and biopsy device markets continue to make up a small proportion of the total market size.
How will device reuse affect revenue growth in these markets?
How will ERCP and biopsy procedure volumes be impacted by epidemiological trends and public participation in screening programs for common GI diseases?
- Gastrointestinal Endoscopy Devices - Market Insights - Latin America
Author(s): Nidhi Nagrath, MBA
Nidhi Nagrath is a research associate within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at DRG (Part of Clarivate), specializing in the gastrointestinal endoscopy device and diagnostic imaging system servicing markets. Nidhi holds a Bachelor's degree in Pharmacy from the University of Delhi and an MBA in Pharmaceutical Marketing from the National Institute of Pharmaceutical Education and Research, Mohali.